Provided by Tiger Trade Technology Pte. Ltd.

ADVANCED HEALTH INTELLIGENCE LTD SPON ADS EACH REP 7 ORD SHS

1.50
0.0000
Volume:- -
Turnover:- -
Market Cap:14.76M
PE:-1.02
High:1.50
Open:1.50
Low:1.50
Close:1.50
52wk High:1.50
52wk Low:1.50
Shares:9.84M
Float Shares:6.39M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4746
EPS(LYR):-1.2933
ROE:-156.27%
ROA:-46.98%
PB:12.83
PE(LYR):-1.16

Loading ...

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025

GlobeNewswire
·
Nov 08

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

GlobeNewswire
·
Oct 30

Advanced Health Intelligence Ltd Delisted from ASX

TIPRANKS
·
Oct 01

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

GlobeNewswire
·
Sep 30

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension

GlobeNewswire
·
Sep 30

Director Scott Montgomery Departs Advanced Health Intelligence

TIPRANKS
·
Sep 16

Advanced Health Intelligence Appoints Dylan Garnett as CEO to Drive Growth

TIPRANKS
·
Sep 16

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

GlobeNewswire
·
Aug 11

Nyxoah Gets FDA Approval for Genio Sleep Apnea Device; Shares Rise After Hours

MT Newswires Live
·
Aug 09

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

GlobeNewswire
·
Aug 08

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

GlobeNewswire
·
Jul 30

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

GlobeNewswire
·
Jul 29

Press Release: Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Dow Jones
·
May 15